SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Westlake Chemical Partners LP (WLKP) trades at a trailing P/E of 6.7, forward P/E of 12.0. Trailing earnings yield is 14.92%, forward earnings yield 8.32%. PEG 0.02 (Peter Lynch undervalued ≤1.0). Graham Number is $41.50.
Criteria proven by this page:
- VALUE (90/100, Pass) — P/E is below market average (6.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); analyst target implies upside (+28.3%); earnings yield beats bond yields (14.92%).
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 14.92% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $29.00 (+28.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 73/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — WLKP
Valuation Multiples
P/E (TTM)6.7
Forward P/E12.0
PEG Ratio0.02
Forward PEG2.56
P/B Ratio1.58
P/S Ratio0.68
EV/EBITDA2.9
Per Share Data
EPS (TTM)$3.36
Forward EPS (Est.)$1.88
Book Value / Share$22.77
Revenue / Share$33.11
FCF / Share$5.72
Yields & Fair Value
Earnings Yield14.92%
Forward Earnings Yield8.32%
Dividend Yield8.37%
Graham Number$41.50
SharesGrow IV$114.47 (+406.5%)
Analyst Target$29.00 (+28.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
14.3 |
-0.31 |
0.64 |
0.59 |
5.96% |
| 2017 |
14.6 |
0.13 |
0.71 |
0.60 |
5.95% |
| 2018 |
15.8 |
-1.43 |
0.83 |
0.61 |
6.86% |
| 2019 |
14.9 |
0.95 |
1.75 |
0.83 |
6.81% |
| 2020 |
12.7 |
2.04 |
1.61 |
0.87 |
7.91% |
| 2021 |
11.5 |
0.47 |
1.76 |
0.78 |
7.02% |
| 2022 |
12.9 |
-0.58 |
1.55 |
0.52 |
8.02% |
| 2023 |
14.1 |
-0.91 |
1.46 |
0.64 |
8.70% |
| 2024 |
13.1 |
0.87 |
1.57 |
0.72 |
8.15% |
| 2025 |
2.2 |
0.01 |
1.34 |
0.57 |
9.93% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.50 |
$986.74M |
$40.94M |
4.1% |
| 2017 |
$1.72 |
$1.17B |
$48.67M |
4.1% |
| 2018 |
$1.51 |
$1.29B |
$49.35M |
3.8% |
| 2019 |
$9.65 |
$1.09B |
$332.9M |
30.5% |
| 2020 |
$9.69 |
$966.67M |
$341.12M |
35.3% |
| 2021 |
$11.40 |
$1.21B |
$401.39M |
33% |
| 2022 |
$9.51 |
$1.59B |
$334.83M |
21% |
| 2023 |
$1.54 |
$1.19B |
$54.28M |
4.6% |
| 2024 |
$1.77 |
$1.14B |
$62.39M |
5.5% |
| 2025 |
$8.47 |
$1.17B |
$298.58M |
25.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.88 |
$1.88 – $1.88 |
$1.37B |
$1.37B – $1.37B |
1 |
| 2027 |
$1.71 |
$1.71 – $1.71 |
$1.44B |
$1.44B – $1.44B |
1 |
| 2028 |
$2.06 |
$2.06 – $2.06 |
$1.5B |
$1.5B – $1.5B |
1 |
